Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes
Go back to Resources
Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes
Authors:
Secondary:
Volume:
Pagination:
ROP outcome in infants with prethreshold ROP and SpO2 ›94% in room air
Go back to Resources
ROP outcome in infants with prethreshold ROP and SpO2 ›94% in room air
Authors:
Location:
Go back to ResourcesRisk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3
Go back to Resources
Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3
Authors:
Secondary:
Volume:
Pagination:
Review of the COBLT Study Processing Procedures
Go back to Resources
Review of the COBLT Study Processing Procedures
Authors:
Location:
Go back to ResourcesReproducibility of p53 immunohistochemistry in bladder tumors
Go back to Resources
Reproducibility of p53 immunohistochemistry in bladder tumors
Authors:
Secondary:
Volume:
Pagination:
Randomized trial of tacrolimus (PROGRAF™) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
Go back to Resources
Randomized trial of tacrolimus (PROGRAF™) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
Authors:
Secondary:
Volume:
Pagination:
randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation
Go back to Resources
randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation
Authors:
Location:
Go back to ResourcesPrimary immunosuppressive agent does not affect Hepatitis C recurrence rates following liver transplantation
Go back to Resources
Primary immunosuppressive agent does not affect Hepatitis C recurrence rates following liver transplantation
Authors:
Location:
Go back to ResourcesPregnancy outcomes in healthy nulliparas who developed hypertension
Go back to Resources
Pregnancy outcomes in healthy nulliparas who developed hypertension
Authors:
Secondary:
Volume:
Pagination: